The world's first Human Digital Twin operating system.全球首个人类数字孪生操作系统。

Costly omics, shelved昂贵的组学，束之高阁

DNA and multi-omics reports cost $100–1,000 a sample, then sit in PDFs — read once and never used again.DNA 与多组学报告每份成本约 $100–1,000，做完却沉睡在 PDF 里 —— 看一次，再不复用。

Siloed & fragmented孤岛与割裂

Check-ups, test reports, medical records and wearables live in separate systems. No one — not even a family doctor — sees a lifelong view.体检、化验报告、病历与可穿戴设备各在不同系统。没有人 —— 甚至家庭医生 —— 能看到一个人贯穿一生的完整视图。

Generic & low-trust笼统且低信任

Direct-to-consumer reports cover a narrow scope with commonsense advice. Those who care about health pay more, yet have no access to reliable, broad insight.面向消费者的报告覆盖面窄、建议笼统。真正关注健康的人付出更多，却得不到可靠、广谱的洞察。

Higher accuracy更高准确度

Multi-omics prediction built on polygenic risk scores lifts accuracy +30–60% over traditional models — reaching up to 0.9 AUC on key diseases (internal testing).以多基因风险评分为核心的多组学预测，较传统模型提升约 +30–60% 准确度 —— 部分关键疾病可达 0.9 AUC（公司内部测算）。

Broader coverage更广覆盖

A single upload analyses 1,000+ phenotypes across 30+ disease categories — where typical direct-to-consumer reports cover fewer than 100.单次上传即可分析 1,000+ 种表型，覆盖 30+ 疾病类别 —— 而同类面向消费者的报告通常覆盖不足 100 项。

Explainable by design生而可解释

Every genetic risk is visualised against a reference population and interpreted live by an AI assistant — not a static PDF.每一项遗传风险都对照参考人群可视化呈现，并由 AI 助手实时解读 —— 而非一份静态 PDF。

From report to operating system从报告到操作系统

Competitors stop at a one-time test. 2HAI turns that data into a lifelong, continuously-updating twin connected to real care and commerce.竞品止步于一次性检测。2HAI 把这些数据变成一个陪伴终身、持续更新，并连接真实诊疗与消费的孪生。

Individuals & families个人与家庭

Lifelong self-management and one continuously-updating personal health twin for the whole family.终身自我管理，为全家打造一个持续更新的个人健康孪生。

Doctors & clinics医生与诊所

Manage patients long-term and run a clinic through the Active Patient Workbench — from data to diagnosis and follow-up.通过“临床工作台（Active Patient Workbench）”长期管理病患、运营诊所 —— 从数据到诊断与随访。

Build a lifelong health twin for a child from infancy, with long-range prediction and prevention from day one.从婴幼儿时期起为孩子建立终身健康孪生，从第一天就开始长期预测与预防。

Enterprises & research企业与科研

Plug in via API for cardiovascular, oncology, neuro/psychiatric and pediatric early-screening applications.通过 API 接入心血管、肿瘤、神经/精神及儿科等早期筛查应用。

G2H-CVD

Cardiovascular disease risk prediction — try the live risk tool today.心血管疾病风险预测 —— 立即体验在线风险评估工具。

G2H-Onco

Cancer early screening — multi-marker, multi-omics modelling.癌症早期筛查 —— 多标志物、多组学建模。

G2H-Neuro

Neurological & psychiatric risk, in cohort collaboration.神经与精神疾病风险，队列合作研究中。

2HAI for Lab

Automated multi-omics analysis for research institutions.面向科研机构的多组学自动化分析。

Decision support, not diagnosis决策支持，而非诊断

2HAI is positioned as health information and clinical decision support — not a diagnostic device or prescription. AI guidance is designed to be validated against current clinical guidelines.2HAI 定位为健康信息与临床决策支持 —— 并非诊断器械或处方。AI 建议须依据现行临床指南进行验证。

Privacy by design隐私即设计

Encryption, de-identification, tiered and user-controlled authorization, and localized storage. Users keep the right to authorize — and revoke — access to their data.加密、去标识化、分级且由用户掌控的授权，以及本地化存储。用户始终保有授权 —— 及撤销 —— 数据访问的权利。

Multi-jurisdiction compliance多法域合规

Aligned with mainland China's PIPL, Data Security Law and human genetic-resources rules, Hong Kong's PDPO, Singapore's PDPA, and GDPR for international markets.遵循中国内地《个人信息保护法》《数据安全法》与人类遗传资源管理规定、香港《私隐条例》（PDPO）、新加坡 PDPA，以及面向国际市场的 GDPR。

Proprietary methodology & IP自主方法学与知识产权

Self-developed statistical-genetics and polygenic-scoring methods, with 2Health AI trademarks registered or pending across key markets.自主研发的统计遗传学与多基因评分方法，“2Health AI”商标在主要市场注册或申请中。